Free shipping on all orders over $ 500

Carbidopa

Cat. No. M3260
Carbidopa Structure
Synonym:

(S)-(-)-Carbidopa

Size Price Availability Quantity
10mM*1mL in DMSO USD 79  USD79 In stock
10mg USD 72  USD72 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Carbidopa is an aromatic-L-amino-acid decarboxylase inhibitor with an IC50 of 29 ± 2 μM. It increases the plasma half-life of levodopa from 50 minutes to 1½ hours. CarbiDOPA cannot cross the blood brain barrier, so it inhibits only peripheral DDC. It thus prevents the conversion of L-DOPA to dopamine peripherally. This reduces the side effects caused by dopamine on the periphery,besides, it increases the concentration of L-DOPA and dopamine in the brain.

Chemical Information
Molecular Weight 226.23
Formula C10H14N2O4
CAS Number 28860-95-9
Form Solid
Solubility (25°C) DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Sandeep Thakkar, et al. 24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical Recommendations

[2] Xiaoli Liao, et al. Levodopa/carbidopa/entacapone for the treatment of early Parkinson's disease: a meta-analysis

[3] Sheridan M Hoy. Levodopa/Carbidopa Enteral Suspension: A Review in Advanced Parkinson's Disease

[4] Lauren C Seeberger, et al. Carbidopa levodopa enteral suspension

[5] C Warren Olanow, et al. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

Related Aryl hydrocarbon Receptor Products
KYN-101

KYN-101 is a potent, selective and orally active AHR inhibitor.

AHR agonist 4

AHR agonist 4 is an agonist of Aryl hydrocarbon receptor (AHR), assocaited with the immune balance of Th17/22 and Treg cells.

Benzyl butyl phthalate

Benzyl butyl phthalate can trigger the migration and invasion of hemangioma (HA) cells via upregulation of Zeb1. Benzyl butyl phthalate activates aryl hydrocarbon receptor (AhR) in breast cancer cells to stimulate SPHK1/S1P/S1PR3 signaling and enhances formation of metastasis-initiating breast cancer stem cells (BCSCs).

Indole-3-ylacetaldehyde

Indole-3-ylacetaldehyde (I3A)

1,4-Chrysenequinone

1,4-Chrysenequinone, a polycyclic aromatic quinone, acts as an activator of aryl hydrocarbon receptor (AhR).

  Catalog
Abmole Inhibitor Catalog




Keywords: Carbidopa, (S)-(-)-Carbidopa supplier, Aryl hydrocarbon Receptor, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.